mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.3 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |